THE DOSE

your daily dose of Innovative, trending, and groundbreaking stories from across the cosmos.


AIsasIA AIsasIA

World Children’s Day: A Day to Honor and Celebrate Children’s Rights

World Children’s Day is a global observance that aims to honor and celebrate the children of the world and their rights. It is observed on November 20 in many countries, including the United States, to coincide with the anniversary of the adoption of the Declaration of the Rights of the Child and the Convention on the Rights of the Child by the United Nations General Assembly.

Read More
AIsasIA AIsasIA

Decriminalization and Therapeutic Use of Psychedelics: A Global Perspective

The global landscape of psychedelic plant medicines and substances is rapidly changing, with many regions decriminalizing these substances and recognizing their therapeutic potential. This article provides a comprehensive analysis of the current state of decriminalization and therapeutic use of psychedelics in the United States and around the world.

Read More
AIsasIA AIsasIA

OpenAI in Crisis as Altman and Brockman Exit, Immediately Hired by Microsoft

In a shocking development, OpenAI CEO Sam Altman and CTO Greg Brockman have suddenly left the prominent AI research company. Sources say the board abruptly fired Altman due to disagreements over commercialization. Brockman then resigned in protest.But both were immediately hired by Microsoft, which looks to gain an edge in the AI race from their experience. Altman will lead Microsoft's AI research division, while Brockman will serve as an architect working on integrations with OpenAI systems.

Read More
AIsasIA AIsasIA

Microsoft and OpenAI Wage All-Out Talent War Over AI Supremacy

Microsoft and OpenAI are locked in a high stakes battle to hoard artificial intelligence talent, with each company poaching engineers and researchers from the other. At the heart of this tug-of-war are OpenAI CEO Sam Altman and CTO Greg Brockman, two of tech's most coveted AI minds.

Read More
AIsasIA AIsasIA

OpenAI Dangles $10 Million Salaries to Poach Google AI Talent

OpenAI, the buzzy AI startup behind ChatGPT, is aggressively recruiting engineers from Google's AI division with pay packages worth up to $10 million, according to a Reuters report. This tactic aims to replenish OpenAI's ranks after losing key personnel to competitors.

Read More
AIsasIA AIsasIA

Psychedelic Startups See Green Rush as Mental Health Uses Mushroom

With a recent boom in psychedelic research, a new wave of startups aims to capitalize on mind-altering compounds like psilocybin for wide-ranging mental health applications. A growing body of evidence suggests psychedelics may help treat conditions like depression, PTSD, and addiction. As attitudes and regulations loosen, investors and entrepreneurs see dollar signs in shrooms.

Read More
AIsasIA AIsasIA

The Bounty of the Seasons: A Guide to Eating Locally and Seasonally for Optimal Health

Eating locally and seasonally provides the optimal nutrition nature intended throughout the year. Each seasonal harvest protects us from deficiencies and provides essential vitamins and minerals when we need them most. Aligning our eating habits with spring cleansing, summer abundance, and autumn insulation enhances vitality, immunity, and overall health.

Read More
AIsasIA AIsasIA

OpenAI Fires Sam Altman, Greg Brockman Steps Down: A New Era Begins

In a shocking turn of events, OpenAI, the leading AI research lab, announced the departure of its CEO, Sam Altman, and the stepping down of Greg Brockman as Chairman of the Board. The news has sent ripples through the AI community, sparking a flurry of speculation and concern about the future direction of the company.

Read More
AIsasIA AIsasIA

Scientists Discover Ancient Anti-Cancer Mechanism: DISE

Scientists from the University of Copenhagen have discovered an ancient anti-cancer mechanism, known as DISE (Death Induced by Survival gene Elimination), that is present in all animals, from worms to humans. This mechanism could potentially be exploited to develop new therapies that target cancer cells without harming normal cells.

Read More